Association Between Amount of Physical Activity and Clinical Outcomes After Treatment for Cardiovascular Disease in Cancer Survivors.
作者信息
Nozaki Kohei, Hamazaki Nobuaki, Kamiya Kentaro, Ueno Kensuke, Miki Takashi, Nanri Yuta, Ogura Ken, Uchida Shota, Maekawa Emi, Nabeta Takeru, Iida Yuichiro, Yamaoka-Tojo Minako, Matsunaga Atsuhiko, Sasaki Jiichiro, Ako Junya
机构信息
Department of Rehabilitation, Kitasato University Hospital Sagamihara Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University Sagamihara Japan.
出版信息
Circ Rep. 2024 Nov 14;6(12):547-554. doi: 10.1253/circrep.CR-24-0105. eCollection 2024 Dec 10.
BACKGROUND
The present study aimed to investigate the association between physical activity before the incidence of cardiovascular disease (CVD) and clinical outcomes in cancer survivors.
METHODS AND RESULTS
We analyzed 904 cancer survivors (median age [interquartile range] 75 [68-80] years; 297 [32.9%] patients were female) who required hospitalization for treatment of CVD. The amount of physical activity 1 month before the admission was assessed using the 3-question (3Q) assessment tool, and categorized as minimal, low, adequate, and high according to physical activity level. The primary outcome was the composite events of all-cause death and/or rehospitalization for CVD up to 1 year after discharge. The total amount of physical activity was identified in 544 (60.2%) patients in the minimal group, 95 (10.5%) in the low group, 253 (28.0%) in the adequate group, and 12 (1.3%) in the high group. A total of 686 (75.9%) patients completed follow up, with 252 (27.9%) composite events occurring. Even after adjustment for various confounders, higher physical activity was significantly associated with a lower composite event rate (adjusted hazard ratio [95% confidence interval] 0.859 [0.833-0.900]).
CONCLUSIONS
High physical activity in cancer survivors was associated with a lower composite event rate after treatment for CVD. Assessment of prehospital physical activity using the 3Q score may be useful in their risk stratification.
相似文献
Cochrane Database Syst Rev. 2022-2-1
Eur J Prev Cardiol. 2022-12-21
Breast Cancer Res Treat. 2021-7
J Am Coll Cardiol. 2022-7-5
本文引用的文献
Eur J Prev Cardiol. 2024-5-11
Curr Probl Cardiol. 2024-1
Eur Heart J. 2023-12-14
Cancer Epidemiol Biomarkers Prev. 2023-12-1